Showing results (61-70 of 119) with videos related to

Sort By:
Pageof 12
Haematologica|June 17, 2008
Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow TransplantationAndré Tichelli, Jakob Passweg, Dorota Wójcik, et al.
Multiple Sclerosis and Related Disorders|June 1, 2025
Comparative analysis of five-year clinical outcomes of autologous hematopoietic stem cell transplantation and alemtuzumab in multiple sclerosis patientsHazal Ceren Manazoğlu, Gülce İşkan, Tuncay Gündüz, et al.
Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology|June 7, 2016
The Role of ABO Incompatibility in Allogeneic Peripheral Blood Stem Cell TransplantÖnder Arslan, Hasan Şanol Coşkun, Mutlu Arat, et al.
Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology|April 21, 2016
Allogeneic Transplantation in Chronic Myeloid Leukemia and the Effect of Tyrosine Kinase Inhibitors on Survival: A Quasi-Experimental StudyMehmet Özen, Celalettin Üstün, Bengi Öztürk, et al.
Bone Marrow Transplantation|March 6, 2021
Prognostic factors for neutrophil engraftment after haploidentical cell transplantation with PT-Cy in patients with acute myeloid leukemia in complete remission, on behalf of the ALWP-EBMTAnnalisa Ruggeri, Myriam Labopin, Emanuele Angelucci, et al.
Haematologica|August 30, 2012
Ongoing graft-versus-host disease is a risk factor for azoospermia after allogeneic hematopoietic stem cell transplantation: a survey of the Late Effects Working Party of the European Group for Blood and Marrow TransplantationAlicia Rovó, Mahmoud Aljurf, Sandra Chiodi, et al.
British Journal of Haematology|August 14, 2025
Graft-versus-host disease is not associated with reduced incidence of relapse following haploidentical stem cell transplantation with post-transplant cyclophosphamide for acute lymphoblastic leukaemia: A study on behalf of the Acute Leukaemia Working Party of European Society for Blood and Marrow TransplantationAvichai Shimoni, Christophe Peczynski, Myriam Labopin, et al.
Cancer|March 19, 2021
Outcome of T-cell-replete haploidentical stem cell transplantation improves with time in adults with acute lymphoblastic leukemia: A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationArnon Nagler, Myriam Labopin, Yener Koc, et al.
Future Oncology (London, England)|June 9, 2023
Unmet clinical needs and challenges in the management of acute leukemia in Turkey: a modified Delphi studyMutlu Arat, Inci Alacacioglu, Ali Zahit Bolaman, et al.
Bone Marrow Transplantation|December 2, 2022
Total body irradiation plus fludarabine versus busulfan plus fludarabine as a myeloablative conditioning for adults with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation. A study on behalf of the Acute Leukemia Working Party of the EBMTRyszard Swoboda, Myriam Labopin, Sebastian Giebel, et al.
Pageof 12